Tag: life sciences
-
Liquid Injectable Electrodes Designed for Nerve Stimulation
In lab animal tests, an injectable silicon-metal material performs as well as conventional electrodes for electrical nerve stimulation, an emerging therapy for pain.
-
New Company Using A.I. to Discover Mental Health Drugs
A new enterprise combining resources from biotechnology and artificial intelligence aims to find safer and more effective treatments for psychiatric disorders.
-
Opioids Provide Few Pain Benefits, Yet Abuse Growing
Opioids appear to provide little benefit for patients with pain from osteoarthritis, yet opioid use disorder rates among patients with painful conditions continue to rise.
-
Infographic – Q3 A.I. Health Investments Set Record
Venture capital funding for companies worldwide building artificial intelligence solutions in health care set new highs in the third quarter of 2019.
-
Phone-Based Infectious Disease Diagnostics Being Developed
An engineering lab is building a system for diagnosing viral infectious diseases with blood samples analyzed by a smartphone add-on.
-
Artificial Kidney Component Passes Preclinical Test
A miniaturized bio-electronic device implanted in a pig can process filtered blood like a real kidney without triggering an immune response or blood clots.
-
Engineered Organ Transplant Company Raises New Funds
An enterprise that applies gene editing to create replacement organs from pigs for human transplant is raising $100 million in new venture financing.
-
Chip Device More Accurate for Drug Toxicity Than Animals
A plastic chip device lined with liver cells is shown to better predict drug toxicity in humans than lab animals, including drugs that progressed to failed clinical trials.
-
AstraZeneca Joins $1B Fund, Expands Footprint in China
The pharmaceutical company AstraZeneca is starting a joint $1 billion health care investment fund in China and vastly increasing its labs and offices there.
-
Small Biz Grants Fund Simpler Aneurysm Tests
Two recent federal small business grants are supporting development of simple tests to screen for unruptured brain aneurysms in asymptomatic patients.